Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical metronidazole for non-healing pilonidal wounds
ACTRN12625000470493Phase 3Not yet recruiting
- Sponsor
- Sydney Colorectal Associates
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in pilonidal cyst comparing Metronidazole ointment with Placebo ointment (2 arms). Primary endpoint: Proportion of patients with complete wound healing by week 8. Planned start May 2025; status: not yet recruiting.
02
Drugs
metronidazole
03
Conditions
pilonidal cyst
Beyond the preview
Go deeper on ACTRN12625000470493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000470493.